Dr. Carl B. Shermetaro
NORTH OAKLAND EAR NOSE AND THROAT CENTERS
5701 Bow Pointe Dr #200
Clarkston, MI, United States
48346
5701 Bow Pointe Dr #200
Clarkston, MI, United States
48346
No Phone Number Provided
No Website Provided
Facility Affiliations
Dr. Carl B. Shermetaro's Credentials
Education
- Chicago College Of Osteopathic Medicine (Grad. 1983)
Insurance accepted by this Doctor
Other patients have successfully used these insurance providers, please call the Doctor's office to find out if your insurance plan is accepted.
Blue Cross / Blue Shield
TRICARE
During my appointment, Dr Shermeraro did NOT examine me. I was seen by two young colleague or student doctors. I only saw Dr Shermetaro for a short time , perhaps 5 minutes. I clearly explained the reason for the appointment to all three. Since birth, I can only hear in one ear. That ear became plugged up after an illness, similar to the pressure one may encounter when descending in an airplane. This decreased my hearing in my good ear. The condition goes away when flying, shortly after becoming airborne, and returns shortly after landing. I was there to find out what might cause that and what might be done to correct it. During my short meeting with Dr Shermetaro, he showed NO interest in gaining any additional information, such as what other treatments I may have had, how long it stayed clear after a flight, etc., even though I tried to discuss it with him. He simply insisted on scheduling an audiogram. Subsequent to the audiogram, I received a short letter from him acknowledging that I could not hear in one ear and the other showed a significant loss of hearing. He offered to provide me with a hearing aid trial. Abosolutely NO mention of the condition for which I had sought his help. A couple final notes. I rated his helpfulness and knowledge low since he did not offer any diagnosis of my condition. He either didn’t care and/or didn’t know how to find out. I was billed an amount much larger then I expected, something I will appeal to my insurance company.
Submitted Feb. 9, 2019